The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives
L Wanka, K Iqbal, PR Schreiner - Chemical reviews, 2013 - ACS Publications
A simple, primary amine bearing a C10H15 alkyl residue was found to display potent anti-
Influenza A properties in 1964. 1 Soon thereafter, antiviral activity of this amine was found …
Influenza A properties in 1964. 1 Soon thereafter, antiviral activity of this amine was found …
Emerging platinum (IV) prodrug nanotherapeutics: A new epoch for platinum-based cancer therapy
S Zheng, G Li, J Shi, X Liu, M Li, Z He, C Tian… - Journal of Controlled …, 2023 - Elsevier
Owing to the unique DNA damaging cytotoxicity, platinum (Pt)-based chemotherapy has
long been the first-line choice for clinical oncology. Unfortunately, Pt drugs are restricted by …
long been the first-line choice for clinical oncology. Unfortunately, Pt drugs are restricted by …
[HTML][HTML] Review on pharmacology of cisplatin: clinical use, toxicity and mechanism of resistance of cisplatin
SA Aldossary - Biomedical and Pharmacology Journal, 2019 - biomedpharmajournal.org
Cisplatin is a chemotherapeutic drug that has been used in the treatment of various types of
human cancers such as ovarian, lung, head and neck, testicular and bladder. Cisplatin has …
human cancers such as ovarian, lung, head and neck, testicular and bladder. Cisplatin has …
Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1
JJ Peluso, X Liu, MM Saunders… - The Journal of …, 2008 - academic.oup.com
Abstract Context: Progesterone (P4) influences ovarian cancer cells by an unknown
mechanism. Objective: The objective was to determine whether P4 acts through …
mechanism. Objective: The objective was to determine whether P4 acts through …
The rational design of anticancer platinum complexes: the importance of the structure-activity relationship
AM Montana, C Batalla - Current medicinal chemistry, 2009 - ingentaconnect.com
The ideal drug discovery process of new platinum based drugs should take into account
three basic fundaments: on one side the mechanisms of action and the corresponding target …
three basic fundaments: on one side the mechanisms of action and the corresponding target …
Inhibition of topoisomerase IIα: novel function of wedelolactone
P Benes, L Knopfova, F Trcka, A Nemajerova… - Cancer letters, 2011 - Elsevier
The naturally occurring coumestan wedelolactone has been previously shown to reduce
growth of various cancer cells. So far, the growth-suppressing effect of wedelolactone has …
growth of various cancer cells. So far, the growth-suppressing effect of wedelolactone has …
Delivery of platinum (II) drugs with bulky ligands in trans-geometry for overcoming cisplatin drug resistance
Drug resistance induced by increasing intracellular levels of detoxifying agents for
conventional platinum (II) drugs such as metallothioneins (MTs) and glutathione (GSH) are …
conventional platinum (II) drugs such as metallothioneins (MTs) and glutathione (GSH) are …
Dual mechanisms of action of the 5-benzylidene-hydantoin UPR1024 on lung cancer cell lines
A Cavazzoni, RR Alfieri, C Carmi, V Zuliani… - Molecular cancer …, 2008 - AACR
In this study, we examined the mechanism of action of the novel epidermal growth factor
receptor (EGFR) tyrosine kinase inhibitor 5-benzylidene-hydantoin UPR1024, whose …
receptor (EGFR) tyrosine kinase inhibitor 5-benzylidene-hydantoin UPR1024, whose …
Ubiquitin-specific peptidase 39 regulates the process of proliferation and migration of human ovarian cancer via p53/p21 pathway and EMT
C Yan, J Yuan, J Xu, G Zhang, X Li, B Zhang, T Hu… - Medical Oncology, 2019 - Springer
Ovarian cancer is one of the most lethal gynecological cancers; owning to its late detection
and chemoresistance, understanding the pathogenesis of this malignant tumor is much …
and chemoresistance, understanding the pathogenesis of this malignant tumor is much …
The new platinum-based anticancer agent LA-12 induces retinol binding protein 4 in vivo
P Bouchal, J Jarkovsky, K Hrazdilova, M Dvorakova… - Proteome science, 2011 - Springer
Background The initial pharmacokinetic study of a new anticancer agent (OC-6-43)-bis
(acetato)(1-adamantylamine) amminedichloroplatinum (IV)(LA-12) was complemented by …
(acetato)(1-adamantylamine) amminedichloroplatinum (IV)(LA-12) was complemented by …